These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17609176)

  • 1. The effect of population structure on the emergence of drug resistance during influenza pandemics.
    Débarre F; Bonhoeffer S; Regoes RR
    J R Soc Interface; 2007 Oct; 4(16):893-906. PubMed ID: 17609176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral resistance and the control of pandemic influenza.
    Lipsitch M; Cohen T; Murray M; Levin BR
    PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing treatment regimes to hinder antiviral resistance in influenza across time scales.
    Patterson-Lomba O; Althouse BM; Goerg GM; Hébert-Dufresne L
    PLoS One; 2013; 8(3):e59529. PubMed ID: 23555694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza.
    Hill AW; Guralnick RP; Wilson MJ; Habib F; Janies D
    Infect Genet Evol; 2009 Mar; 9(2):169-78. PubMed ID: 19022400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
    Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
    PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global spread of drug-resistant influenza.
    Chao DL; Bloom JD; Kochin BF; Antia R; Longini IM
    J R Soc Interface; 2012 Apr; 9(69):648-56. PubMed ID: 21865253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza viruses resistant to neuraminidase inhibitors.
    Nitsch-Osuch A; Brydak LB
    Acta Biochim Pol; 2014; 61(3):505-8. PubMed ID: 25195142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture].
    Fediakina IT; Shchelkanov MIu; Deriabin PG; Leneva IA; Gudova NV; Kondrat'eva TV; L'vov DK
    Antibiot Khimioter; 2011; 56(3-4):3-9. PubMed ID: 21913403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012.
    Hoang Vu MP; Nguyen CT; Nguyen le KH; Nguyen TK; Le QM
    Western Pac Surveill Response J; 2013; 4(2):25-9. PubMed ID: 24015368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.
    Handel A; Longini IM; Antia R
    J Theor Biol; 2009 Jan; 256(1):117-25. PubMed ID: 18952105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.
    Moss RB; Davey RT; Steigbigel RT; Fang F
    J Antimicrob Chemother; 2010 Jun; 65(6):1086-93. PubMed ID: 20375034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza virus resistance to antiviral agents: a plea for rational use.
    Poland GA; Jacobson RM; Ovsyannikova IG
    Clin Infect Dis; 2009 May; 48(9):1254-6. PubMed ID: 19323631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam.
    Le MT; Wertheim HF; Nguyen HD; Taylor W; Hoang PV; Vuong CD; Nguyen HL; Nguyen HH; Nguyen TQ; Nguyen TV; Van TD; Ngoc BT; Bui TN; Nguyen BG; Nguyen LT; Luong ST; Phan PH; Pham HV; Nguyen T; Fox A; Nguyen CV; Do HQ; Crusat M; Farrar J; Nguyen HT; de Jong MD; Horby P
    PLoS One; 2008 Oct; 3(10):e3339. PubMed ID: 18836532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The timing and targeting of treatment in influenza pandemics influences the emergence of resistance in structured populations.
    Althouse BM; Patterson-Lomba O; Goerg GM; Hébert-Dufresne L
    PLoS Comput Biol; 2013; 9(2):e1002912. PubMed ID: 23408880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.
    Inoue M; Barkham T; Leo YS; Chan KP; Chow A; Wong CW; Tze Chuen Lee R; Maurer-Stroh S; Lin R; Lin C
    Emerg Infect Dis; 2010 Oct; 16(10):1633-6. PubMed ID: 20875299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
    Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
    Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cracking the code for H5N1-bird flu and beyond.
    Thomson RJ; Haselhorst T; Dyason JC; von Itzstein M
    Curr Drug Deliv; 2009 Aug; 6(4):343-6. PubMed ID: 19534713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational studies of H5N1 influenza virus resistance to oseltamivir.
    Wang NX; Zheng JJ
    Protein Sci; 2009 Apr; 18(4):707-15. PubMed ID: 19309695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.